Insider · CIK 0001827326
Jeffrey Eisele
officer
Files at APLS (Apellis Pharmaceuticals, Inc.). First filing Dec 27, 2024, latest Jan 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $57k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Apellis Pharmaceuticals, Inc. | $8,208 278 shares | -1% | - | |
| 36Weak | Apellis Pharmaceuticals, Inc. | $39k 1,291 shares | -2% | - | |
| 30Weak | Apellis Pharmaceuticals, Inc. | $7,577 264 shares | -0% | - | |
| 30Weak | Apellis Pharmaceuticals, Inc. | $2,085 63 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -278 | $29.52 | $8,208 | 55,312 | Jan 30, 2025 |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,291 | $30.43 | $39k | 55,590 | Jan 23, 2025 |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -264 | $28.70 | $7,577 | 56,881 | Jan 14, 2025 |
| Dec 23, 2024 | APLS Apellis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -63 | $33.09 | $2,085 | 57,145 | Dec 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.